2058 related articles for article (PubMed ID: 7722017)
21. Prevalence of melanocytic nevi and freckles in young Israeli males. Correlation with melanoma incidence in Jewish migrants: demographic and host factors.
Pavlotsky F; Azizi E; Gurvich R; Lusky A; Barell V; Weiner M; Iscovich J
Am J Epidemiol; 1997 Jul; 146(1):78-86. PubMed ID: 9215225
[TBL] [Abstract][Full Text] [Related]
22. A pooled analysis of melanocytic nevus phenotype and the risk of cutaneous melanoma at different latitudes.
Chang YM; Newton-Bishop JA; Bishop DT; Armstrong BK; Bataille V; Bergman W; Berwick M; Bracci PM; Elwood JM; Ernstoff MS; Green AC; Gruis NA; Holly EA; Ingvar C; Kanetsky PA; Karagas MR; Le Marchand L; Mackie RM; Olsson H; Østerlind A; Rebbeck TR; Reich K; Sasieni P; Siskind V; Swerdlow AJ; Titus-Ernstoff L; Zens MS; Ziegler A; Barrett JH
Int J Cancer; 2009 Jan; 124(2):420-8. PubMed ID: 18792098
[TBL] [Abstract][Full Text] [Related]
23. Prevalence of common and atypical melanocytic nevi in Turkish children.
Akyol M; Atli AG; Ozçelik S; Cinar Z; Cig FA; Bircan H
Eur J Dermatol; 2008; 18(4):422-6. PubMed ID: 18573716
[TBL] [Abstract][Full Text] [Related]
24. Number of melanocytic nevi as a major risk factor for malignant melanoma.
Holly EA; Kelly JW; Shpall SN; Chiu SH
J Am Acad Dermatol; 1987 Sep; 17(3):459-68. PubMed ID: 3655025
[TBL] [Abstract][Full Text] [Related]
25. Common melanocytic nevi in 7-year-old schoolchildren residing at different latitudes in Sweden.
Rodvall Y; Wahlgren CF; Ullén H; Wiklund K
Cancer Epidemiol Biomarkers Prev; 2007 Jan; 16(1):122-7. PubMed ID: 17220340
[TBL] [Abstract][Full Text] [Related]
26. Count of benign melanocytic nevi as a major indicator of risk for nonfamilial nodular and superficial spreading melanoma.
Grob JJ; Gouvernet J; Aymar D; Mostaque A; Romano MH; Collet AM; Noe MC; Diconstanzo MP; Bonerandi JJ
Cancer; 1990 Jul; 66(2):387-95. PubMed ID: 2369719
[TBL] [Abstract][Full Text] [Related]
27. Association of Patient Risk Factors and Frequency of Nevus-Associated Cutaneous Melanomas.
Haenssle HA; Mograby N; Ngassa A; Buhl T; Emmert S; Schön MP; Rosenberger A; Bertsch HP
JAMA Dermatol; 2016 Mar; 152(3):291-8. PubMed ID: 26536613
[TBL] [Abstract][Full Text] [Related]
28. Identification of melanoma risk factors in the Polish population.
Dabkowski J; Omulecki A; Zalewska A
Dermatol Surg; 1997 Nov; 23(11):1039-42. PubMed ID: 9391561
[TBL] [Abstract][Full Text] [Related]
29. Constitutional and environmental risk factors for cutaneous melanoma in an Italian population. A case-control study.
Fargnoli MC; Piccolo D; Altobelli E; Formicone F; Chimenti S; Peris K
Melanoma Res; 2004 Apr; 14(2):151-7. PubMed ID: 15057047
[TBL] [Abstract][Full Text] [Related]
30. A retrospective cohort study of Southeast Asian patients with large congenital melanocytic nevi and the risk of melanoma development.
Chan YC; Giam YC
J Am Acad Dermatol; 2006 May; 54(5):778-82. PubMed ID: 16635657
[TBL] [Abstract][Full Text] [Related]
31. Risk of melanoma in medium-sized congenital melanocytic nevi: a follow-up study.
Sahin S; Levin L; Kopf AW; Rao BK; Triola M; Koenig K; Huang C; Bart R
J Am Acad Dermatol; 1998 Sep; 39(3):428-33. PubMed ID: 9738777
[TBL] [Abstract][Full Text] [Related]
32. Body-site distribution of common acquired melanocytic nevi associated with severe sunburns among children in Lithuania.
Valiukeviciene S; Gollnick H; Stang A
Int J Dermatol; 2007 Dec; 46(12):1242-9. PubMed ID: 18173516
[TBL] [Abstract][Full Text] [Related]
33. Counts of common and atypical melanocytic nevi in Korean young men: assessment of their risks and correlations with associated factors.
Kim YG; Cho KH
J Dermatol; 1996 May; 23(5):315-9. PubMed ID: 8675820
[TBL] [Abstract][Full Text] [Related]
34. Personal risk-factor chart for cutaneous melanoma.
MacKie RM; Freudenberger T; Aitchison TC
Lancet; 1989 Aug; 2(8661):487-90. PubMed ID: 2570195
[TBL] [Abstract][Full Text] [Related]
35. The epidemiology of acquired melanocytic nevi. A brief review.
Gallagher RP; McLean DI
Dermatol Clin; 1995 Jul; 13(3):595-603. PubMed ID: 7554507
[TBL] [Abstract][Full Text] [Related]
36. Risk factors for developing cutaneous melanoma and criteria for identifying persons at risk: multicenter case-control study of the Central Malignant Melanoma Registry of the German Dermatological Society.
Garbe C; Büttner P; Weiss J; Soyer HP; Stocker U; Krüger S; Roser M; Weckbecker J; Panizzon R; Bahmer F
J Invest Dermatol; 1994 May; 102(5):695-9. PubMed ID: 8176250
[TBL] [Abstract][Full Text] [Related]
37. Use of host factors to identify people at high risk for cutaneous malignant melanoma .
Marrett LD; King WD; Walter SD; From L
CMAJ; 1992 Aug; 147(4):445-53. PubMed ID: 1498755
[TBL] [Abstract][Full Text] [Related]
38. Risk of melanoma arising in large congenital melanocytic nevi: a systematic review.
Watt AJ; Kotsis SV; Chung KC
Plast Reconstr Surg; 2004 Jun; 113(7):1968-74. PubMed ID: 15253185
[TBL] [Abstract][Full Text] [Related]
39. Epidemiologic evidence for the role of melanocytic nevi as risk markers and direct precursors of cutaneous malignant melanoma. Results of a case control study in melanoma patients and nonmelanoma control subjects.
Krüger S; Garbe C; Büttner P; Stadler R; Guggenmoos-Holzmann I; Orfanos CE
J Am Acad Dermatol; 1992 Jun; 26(6):920-6. PubMed ID: 1607409
[TBL] [Abstract][Full Text] [Related]
40. Benign melanocytic lesions: risk markers or precursors of cutaneous melanoma?
Skender-Kalnenas TM; English DR; Heenan PJ
J Am Acad Dermatol; 1995 Dec; 33(6):1000-7. PubMed ID: 7490345
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
